MiR-375 Inhibitor Alleviates Inflammation and Oxidative Stress by Upregulating the GPR39 Expression in Atherosclerosis
International Heart Journal · 2024
DOI: 10.1536/ihj.23-155 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Heart Journal, 2024. Verfasst von Hui Luo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Hospital of Changsha. Hauptthemen laut MEDLINE: MicroRNAs, Atherosclerosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Hospital of Changsha.
- Department of Cardiovascular Medicine, The Third Xiangya Hospital, Central South University.
- Center for Reproductive Medicine, The Third Xiangya Hospital, Central South University.
Zitieren
APA
Luo, H., Zhao, L., Dong, B., & Liu, Y. (2024). MiR-375 Inhibitor Alleviates Inflammation and Oxidative Stress by Upregulating the GPR39 Expression in Atherosclerosis. International Heart Journal. https://doi.org/10.1536/ihj.23-155
Vancouver
Luo H, Zhao L, Dong B, Liu Y. MiR-375 Inhibitor Alleviates Inflammation and Oxidative Stress by Upregulating the GPR39 Expression in Atherosclerosis. International Heart Journal. 2024. doi:10.1536/ihj.23-155
BibTeX
@article{Luo2024,
author = {Luo, Hui and Zhao, Lin and Dong, Bo and Liu, Yanghong},
title = {MiR-375 Inhibitor Alleviates Inflammation and Oxidative Stress by Upregulating the GPR39 Expression in Atherosclerosis},
journal = {International Heart Journal},
year = {2024},
doi = {10.1536/ihj.23-155}
}
EUVIMED